Dihydromyricetin Attenuates Diabetic Cardiomyopathy by Inhibiting Oxidative Stress, Inflammation and Necroptosis via Sirtuin 3 Activation
Dihydromyricetin (DHY), the main flavonoid component in <i>Ampelopsis grossedentata</i>, has important benefits for health. The present study aimed to investigate the exact effects and possible mechanisms of DHY on diabetic cardiomyopathy (DCM). Male C57BL/6 mice and sirtuin 3 (SIRT3) kn...
Egile Nagusiak: | Yun Chen, Yangyang Zheng, Ruixiang Chen, Jieru Shen, Shuping Zhang, Yunhui Gu, Jiahai Shi, Guoliang Meng |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
MDPI AG
2023-01-01
|
Saila: | Antioxidants |
Gaiak: | |
Sarrera elektronikoa: | https://www.mdpi.com/2076-3921/12/1/200 |
Antzeko izenburuak
-
Dihydromyricetin regulates RIPK3-CaMKII to prevent necroptosis in high glucose-stimulated cardiomyocytes
nork: Linlin Sun, et al.
Argitaratua: (2024-04-01) -
Prognostic signature and therapeutic drug identification for dilated cardiomyopathy based on necroptosis via bioinformatics and experimental validation
nork: Han Yang, et al.
Argitaratua: (2025-01-01) -
Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice
nork: Fei Teng, et al.
Argitaratua: (2025-12-01) -
The protection effect of dihydromyricetin and its acylated derivatives on oxidative damage of hepatocytes
nork: DU Bao-shuang, et al.
Argitaratua: (2022-09-01) -
A designed self-microemulsifying delivery system: Stability and Anti-inflammation in vivo enhancement of dihydromyricetin
nork: Yimei Zheng, et al.
Argitaratua: (2024-07-01)